Recurrent copy number variations as risk factors for autism spectrum disorders: analysis of the clinical implications

Clinical Genetics
V OikonomakisM Tzetis

Abstract

Chromosomal microarray analysis (CMA) is currently considered a first-tier diagnostic assay for the investigation of autism spectrum disorders (ASD), developmental delay and intellectual disability of unknown etiology. High-resolution arrays were utilized for the identification of copy number variations (CNVs) in 195 ASD patients of Greek origin (126 males, 69 females). CMA resulted in the detection of 65 CNVs, excluding the known polymorphic copy number polymorphisms also found in the Database of Genomic Variants, for 51/195 patients (26.1%). Parental DNA testing in 20/51 patients revealed that 17 CNVs were de novo, 6 paternal and 3 of maternal origin. The majority of the 65 CNVs were deletions (66.1%), of which 5 on the X-chromosome while the duplications, of which 7 on the X-chromosome, were rarer (22/65, 33.8%). Fifty-one CNVs from a total of 65, reported for our cohort of ASD patients, were of diagnostic significance and well described in the literature while 14 CNVs (8 losses, 6 gains) were characterized as variants of unknown significance and need further investigation. Among the 51 patients, 39 carried one CNV, 10 carried two CNVs and 2 carried three CNVs. The use of CMA, its clinical validity and utility was assessed.

References

Dec 7, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Christelle M DurandThomas Bourgeron
Jan 19, 2006·Nature Reviews. Genetics·Lars FeukStephen W Scherer
Aug 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sébastien KickaPhilippe Silar
Mar 14, 2007·Molecular and Cellular Biology·Natasha IlesKeith W Caldecott
Jan 11, 2008·The New England Journal of Medicine·Lauren A WeissUNKNOWN Autism Consortium
Jan 17, 2008·European Journal of Human Genetics : EJHG·Pietro ChiurazziGiovanni Neri
May 30, 2009·Current Opinion in Genetics & Development·Brent R Bill, Daniel H Geschwind
Oct 21, 2009·American Journal of Medical Genetics. Part a·Ascensión Vera-CarbonellIsabel López-Expósito
Jan 13, 2010·Journal of Autism and Developmental Disorders·S Hossein FatemiPaul D Thuras
Feb 6, 2010·European Journal of Medical Genetics·Feng LiDenise A S Batista
Feb 16, 2010·Nature Genetics·Santhosh GirirajanEvan E Eichler
Apr 29, 2010·American Journal of Medical Genetics. Part a·Anna LindstrandElisabeth Blennow
Aug 11, 2011·BMC Medical Genetics·Anne GregorChristiane Zweier
Nov 9, 2011·Gene·Maria Santa RoccaVanna Pecile
May 1, 2012·American Journal of Human Genetics·Lia Abbasi-MohebAndreas W Kuss
May 1, 2012·Nature Genetics·David A KoolenBert B A de Vries
May 1, 2012·Nature Genetics·Marcella ZollinoGiuseppe Marangi
Jun 19, 2012·Expert Review of Molecular Diagnostics·Maria TzetisEmmanuel Kanavakis
Jul 7, 2012·Brain Research·Christoph RediesChristian A Hübner
Aug 2, 2012·Genome Biology·Jamee M Berg, Daniel H Geschwind
Aug 2, 2012·The International Journal of Neuropsychopharmacology·Marco BortolatoJean C Shih
Aug 4, 2012·ACS Chemical Neuroscience·Aileen HealyTimothy Ocain
Sep 11, 2012·Journal of Neurodevelopmental Disorders·Bernard J Crespi, Helen J Crofts
Sep 14, 2012·The New England Journal of Medicine·Santhosh GirirajanEvan E Eichler
Feb 22, 2013·Current Opinion in Neurology·Danielle Posthuma, Tinca J C Polderman
Mar 15, 2013·Neuroscience Letters·Xiaofei XiuHao Deng
Jul 4, 2013·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Silvia BassaniMaria Passafaro
Mar 13, 2014·Gene·Isabela M W SilvaVanessa S Sotomaior
Apr 29, 2014·American Journal of Human Genetics·Dalila PintoStephen W Scherer
Apr 30, 2014·Case Reports in Genetics·K M UsreyM G Butler
May 16, 2014·European Journal of Human Genetics : EJHG·Maria TropeanoDavid A Collier
Jul 8, 2014·Molecular Autism·Chia-Hsiang ChenSusan Shur-Fen Gau

❮ Previous
Next ❯

Citations

Jul 2, 2017·Molecular Biology and Evolution·Mizuka Sekine, Takashi Makino
Jul 24, 2020·Fetal and Pediatric Pathology·Vandana KamathMary Purna Chacko
Jul 25, 2018·Molecular Diagnosis & Therapy·Shannon RoseRichard E Frye
Jul 8, 2020·International Journal of Molecular Sciences·Ann Genovese, Merlin G Butler
Oct 14, 2017·Journal of Autism and Developmental Disorders·Eleonora NapoliStefano Vicari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Related Papers

Genetics in Medicine : Official Journal of the American College of Medical Genetics
Michael E CoulterMira Irons
Journal of Paediatrics and Child Health
Katherine B HowellRichard J Leventer
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Wen-zhi HeXiaofang Sun
© 2022 Meta ULC. All rights reserved